Skip to content
Home/ Diverse Effects of Hypoxia on Tumor Progression (2010)
Diverse Effects of Hypoxia on Tumor Progression (2010)

Diverse Effects of Hypoxia on Tumor Progression (2010)

No customer reviews yet ISBN 9783642264849

Hypoxia, defined as reduced oxygen tension, is a common physiological phenomenon in both normal embryonic development and malignancy progression. Although severe hypoxia is generally toxic for both normal tissue and tumors, neoplastic cells gradually adapt to prolonged hypoxia though additional genetic and genomic changes with a net result that hypoxia promotes tumor progression and therapeutic resistance. Hypoxia promotes cancer progression by regulating various aspects of cancer biology, including radiotherapy resistance, metabolism, angiogenesis and invasion/migration

About the author

Product details

Pub dateNov 5, 2012
ISBN-103642264840
ISBN-139783642264849
LanguageEnglish
Last updated 2026-06-21 07:32
$177.01
In stock — ships in 24 hours with free tracking
Delivery by Wednesday, October 21, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Oncology - General
See all
Facing Cancer: A Complete Guide for People with Cancer, Their Families, and Caregivers
Stern, Theodore
$20.36
Cancer Pain Management
Fisch, Michael
$251.58
MD Anderson Manual of Psychosocial Oncology
Duffy, James D
$101.14
Gynecologic Oncology: Clinical Practice and Surgical Atlas
Karlan, Beth Y
$320.70
Harrison's Manual of Oncology
Chabner, Bruce a
$95.77
Advances in Cancer Research
Volume 68 of <b>Advances in Cancer Research</b> continues the tradition of publishing up-to-date reviews and "hot" topics in cancer research. This volume begins with a "Foundations in Cancer Research" article by Harald zur Hausen that reviews his years of research on the idea that cancer can be triggered by infection. The structure and function of the cytokine receptor superfamily and its association with leukemias are discussed in depth by James Ihle. Marcia Hall and Gordon Peters review the evidence indicating that genetic abnormalities hinder the function of certain cyclins and their inhibitors. The most widely studied protooncogene, c-<i>myc</i>, is reviewed by Marie Henriksson and Bernhard Lüscher&#x3b; the chapter focuses on the function of c-<i>myc</i> as a transcription factor rather than on the effects of gene translocation and activation on malignancies. Ham Werner and Derek LeRoith present data on the role that insulin-like growth factors play on cell growth and regulation. In the final chapter, Olli-P. Kallioniemi and Tapio Visakorpi investigate the field of prostate cancer and, more importantly, the biological reason and natural history behind the growth of this cancer.
$103.10